Introduction
Enteroviruses, particularly group B coxsackieviruses, have been implicated by serological studies as a major cause of viral myocarditis (Smith, 1970; Koontz & Ray, 1971 ; Schmidt et al., 1973; Grist & Bell, 1973; MorganCapner et al., 1984) . However, with the exception of myocarditis in newborns, it has been very difficult to demonstrate the presence of virus in cardiac tissues from human patients with myocarditis either by viral culture or immunohistochemical analysis (Sutton et al., 1963 (Sutton et al., , 1967 Burch et al., 1967 Burch et al., , 1968 .
The development of specific enterovirus probes and RNA detection techniques has resulted in further evidence to support the role of enteroviruses in the causation of myocarditis. Using slot-blot analysis, Bowles et al. (1986 Bowles et al. ( , 1989 first demonstrated the presence of enterovirus RNA in heart muscle. Furthermore, enteroviral RNA has been detected by in situ hybridization using a probe for a highly conserved RNA region (Kandolf et al., 1988) , in a myocardial explant of a patient who underwent heart transplantation. Similarly, viral RNA has been localized in cardiac tissues from patients with myocarditis using a probe for the 3' half of 0001-2349 © 1994 SGM the coxsackievirus B3 (CVB3) genome . The presence of enteroviral RNA has been demonstrated by reverse transcriptase (RT)-PCR in endomyocardial biopsy specimens from patients with myocarditis and dilated cardiomyopathy (Jin et al., 1990; Weiss et al., 1991; Petitjean et al., 1992) . These results suggest that the presence of enteroviral RNA is associated with histologically identified human myocarditis and possibly that human myocarditis progresses to dilated cardiomyopathy.
Experimentally-induced CVB3 myocarditis in the mouse is a well-established animal model for the study of the pathogenesis of enteroviral myocarditis. The finding of an association between diminished clearance of CVB3 and increased or delayed myocardial necrosis in the immunosuppressed murine model supports the association between persistent viral replication in the development of myocarditic lesions (Khatib et al., 1987) . However, there are several reports suggesting that T cell immunity in itself plays a role in the development of murine myocarditis (Woodruff, 1980; Leslie et al., 1989; Loudon et al., 1991) . Specifically, adoptive transfer of autoreactive T cells to T cell-deficient mice inoculated with CVB3 produces severe myocarditis, in contrast to the transfer of virus-specific cytotoxic T cells (Huber & Lodge, 1984) . However, pathological evidence suggests that healing is accelerated in immunocompetent mice compared to T cell-deficient mice, in which initial lesions are quite extensive and persistent (Chow et al., 1991; Klingel et al., 1992) . These results indicate that T cell immunity is not a prerequisite for the development of myocarditis in certain mouse models.
Because persistent viral infection may lead to chronic myocardial damage in humans, we believe that the mechanisms of persistent infection should be investigated using the mouse model and compared with self-limited infection. To this end, we studied the relationship between persistent infection with CVB3 and the extent of myocardial damage up to 92 days post-inoculation (p.i.) in the C3H/HeN strain of mouse, in both immunocompetent euthymic (nu/+) and athymic (nu/nu) genotypes.
Methods
Virus and animals. CVB3 Nancy strain was kindly provided by Dr C. Gauntt (Texas University, Tex., U.S.A.) and propagated in HeLa cells at a low m.o.i. Six-to 8-week-old inbred C3H/HeN mice (H-U; Harlan Sprague; 69 genotype nu/+ and 40 nu/nu) were inoculated intraperitoneally with 106 p.f.u, of CVB3 and sacrificed as scheduled (Table 1) . At several time points, blood was drawn without sacrificing the animal. One mock-infected nu/+ mouse became severely ill and was autopsied 2 days p.i. One infected nu/+ died 3 weeks p.i. All athymic mice were sacrificed on schedule.
Purified CVB3 was prepared by two rounds of CsC1 gradient ultracentrifugation (25000 r.p.m, overnight) using a Beckman SW41 rotor.
Heart purfusion and myocardium processing. Blood of mice was drawn directly from the heart before opening the chest. Each mouse was autopsied aseptically with a new set of surgical instruments. The heart was transfused with physiological saline for 2 to 3 rain before removal. The ventricle portion of the myocardium was dissected transversely into three pieces. The apex was further divided into four equal parts, which were placed into Eppendorf tubes, snap-frozen in liquid nitrogen and kept at -70 °C until used for RNA extraction. The mid-portion was mounted with embedding medium (O.C.T. compound; Miles) and frozen in liquid nitrogen, for immunohistochemical analysis and in situ hybridization. The third portion near the base of the heart was fixed in 10% buffered formalin, embedded in paraffin, sectioned, mounted on glass slides and stained with haematoxylin-eosin for histological analysis.
Morphological analysis. For each heart, an image of the histological section of myocardium was projected onto paper and the perimeter of the myocardial tissue as well as the lumen were traced. Using computer software (Morphometer version 1.3, Woods Hole Educational Associates) the area of the myocardial tissue was determined by computing the total area and subtracting the luminal area. Similarly, each myocarditic lesion was traced and the sum of the lesional area computed. The ratio of the lesional area to the total myocardial area was determined for each heart section.
Titration of virus.
Infectious CVB3 in the myocardial tissue or the whole blood was titrated by the plaque method. Three to 10 mice were studied at each time point. Hanks' balanced salt solution was added to the wet myocardial tissue at a ratio of 100 pl/mg. The tissue was mixed with sterilized glass beads and homogenized on ice using a plastic conical grinder. The homogenates were then clarified by centrifugation and the liquid phase was removed for titration. The supernatant or the whole blood was diluted 10-fold with Hanks' balanced salt solution supplemented with 2% fetal calf serum. A sample (100 ~tl) of each dilution was inoculated onto confluent HeLa cells prepared in six-well Nunc plastic plates. After adsorption for 60 min, cells were washed and overlaid with medium consisting of Eagle's MEM, 2 % fetal bovine serum and 1% Noble agar (Difco). Plaques were counted after staining the cells with 0.2 % gentian violet in 10 % buffered formalin at day 3 p.i.
Neutralization tests. Neutralizing antibody to CVB3 was assayed using sera from nu/+ and nu/nu mice obtained at days 21 and 42 p.i.
Sera were diluted twofold with Hanks' balanced salt solution and mixed with 100 TCID~0 of CVB3, incubated for 60 min at 37 °C and inoculated in duplicate onto HeLa cells in 96-well microplates. The c.p.e, was observed daily and the endpoints were determined 4 days p.i. Titres over 1:4 were considered neutralization-positive.
RNA probes for CVB3. A CVB3 cDNA clone (pGP29-35), which contains the nucleotides of a coding region spanning 1200 to 3140 bp of published CVB3 sequence (Tracy et al., 1985) in a pGEM-1 transcription vector (Promega), was kindly supplied by Dr S. Tracy (University of the Nebraska Medical Center, Neb., U.S.A.). The 35S-labelled RNA probes for CVB3 plus-or minus-strand RNA were synthesized from the clone using either T7 or SP6 RNA polymerase.
In situ hybridization. Frozen heart tissue sections (8 pm) were fixed in 4% paraformaldehyde, defatted with chloroform and treated with 0.25 % acetic anhydride in 0.1 M-triethanolamine pH 8.0. Hybridization proceeded as previously described (Sato et al., 1993) . Sections were incubated at 85°C in prehybridization solution [50% deionized formamide, 0-6 M-NaC1, 0.01 M-Tris-HC1, 0.02 % (w/v) Ficoll, 0.02 % * Mice were sacrificed by CO 2 suffocation and blood was drawn by cardiac puncture.
"}" The blood was drawn either from the orbital sinus or tail vein.
(w/v) BSA, 0-02% (w/v) polyvinylpyrolidone, 1 mM-EDTA, 0.1 mg sonicated DNA, 1 mg/ml total yeast RNA, 0.25 mg/ml yeast tRNA].
The strand-specific 35S-labelled CVB3 RNA probe was heated at 85 °C for 5 min and added to the hybridization solution (prehybridization solution plus 0.1% SDS, 100 mM-dithiothreitol, 100 mg/ml dextran sulphate). Hybridization proceeded at 50 °C overnight in a humid chamber with 0.5 x 106 c.p.m, of the probe/section. After incubation, the slides were rinsed twice with 2 × SSC and treated with 0.02 mg/ml RNase A in buffer (10 mM-Tris HCI pH 8-0, 0.5 M-NaC1, 1 mM-EDTA) for 30 min at room temperature. After further rinsing with 2 x SSC at 50 °C for 1 h and 0.2 x SSC at 60 °C for 2 h, the slides were immersed in NTB2 emulsion (Kodak) and exposed for 1 week at -20 °C.
Immunohistochemical analysis. Perforin in infiltrating cells was detected as previously described (Seko et al., 1991) . Briefly, 8 ~tm cryostat sections were fixed in acetone for 3 min at 4 °C, washed in PBS, incubated in 0.3 % H202 in methanol for 20 min, washed again and incubated in 0-5% periodic acid for 10rain. The sections were incubated with rat anti-mouse perforin monoclonal antibody for 1 h at 37 °C, washed in PBS and incubated with biotinylated anti-rat IgG antibody (Zymed Laboratories). The sections were incubated with streptavidin-peroxidase conjugate (BRL) for 1 h at 37 °C, washed and reacted with diaminobenzidine tetrahydrochloride (BRL).
RNA preparation. Total RNA was extracted from frozen myocardium using guanidinium thiocyanate (Kingston, 1991) . A piece of myocardium tissue (5 to 10 mg) from each mouse was lysed with 6-0 Mguanidinium thiocyanate, 6-0raM-sodium citrate, 0.5% sodium sarcocine, 0.12 M-2-mercaptoethanol, pH 7.5. RNA was separated from DNA by CsCI (pH 7.5, 5.7 M-CsCI, 0"1 M-EDTA) ultracentrifugation in a Beckman SW-60 rotor at 35000 r.p.m, for 18 h. The pellet was resuspended in diethyl pyrocarbonate-treated water and precipitated by two volumes of ethanol-sodium acetate. CVB3-infected HeLa cells were treated in the same manner. Viral RNA from purified virus was obtained by phenol-chloroform-isoamyl alcohol extraction. RNase inhibitor (40 units; BRL) was added to the preparations, which were stored at -70 °C until use.
RTPCR.
A set of primers and a probe for CVB3, located in the VPI region, were used as previously described (Sato et al., 1993) : a sense primer (position 2691, 5' AACTCAGGTGCCAAGCGGTATGCTG Y), an antisense primer (2870, 5' TTGGTGTGTTAGGATCTG-TGCGTCT 3'), and a probe for the sense sequence (2820, 5' CAGTACTTGTGACAAACGTCAGCTCCAGGTCGAAC 3'). Complementary DNA for plus-or minus-strand RNA was produced by means of cloned Moloney murine leukaemia virus RT (BRL) using one of the primers. Extracted RNA (1 ~g) was used for each RT reaction. Amplification proceeded in a programmable thermal cycler (Perkin-Elmer, Cetus) for 25 cycles with denaturation at 95 °C for 2 min, annealing at 50 °C for 2 rain and extension at 72 °C for 2 rain. Denaturation at 95 °C for 5 min and extension at 72 °C for 5 rain were performed before and after the cycles, respectively. PCR products (180 bp) were visualized by either agarose gel electrophoresis with ethidium bromide staining or by means of liquid hybridization (Schnittman et at., 1989) : 10 ~1 of PCR product was mixed with 100 000 c.p.m, of a 32p-labelled probe and heated at 95 °C for 2 min, then hybridized at 56 °C for 15 min. The hybridized heteroduplexes were resolved by electrophoresis using a 10 % polyacrylamide gel. The gel was covered with Saran wrap and exposed to Kodak X-Omat AR film at -70 °C in the presence of an intensifying screen.
The primers and the probe for amplification and detection of murine tumour necrosis factor-~ (TNF~) mRNA were derived from the previously published sequence (Fransen et al., 1985) : sense primer (position 517, 5' GATCTCAAAGACAACCAAATAGTG 3'), antisense primer (771, 5' CTCCAGCTGGAAGACTCCTCCCAG 3'), and the probe for the antisense sequence (601, 5' CCCGACTACGTGC-TCCTCACC 3'). The amplification protocol was the same as the above except for annealing at 55 °C. The PCR product was analysed by liquid hybridization.
Results

Histology
Myocarditic lesions developed in virtually all infected mice, with important differences depending upon their genotype (see below). Myocarditic lesions were not present in control animals. A myocarditic lesion was defined as an area of inflammatory cells with associated myocyte loss. In acute lesions, myocyte loss was characterized by necrosis of myocyte cytoplasm with cellular dissolution. In healing lesions, necrosis was variable or absent and myocytes were replaced by a cellular ingrowth of fibroblasts or a relatively acellular area of collagen.
In nu/+ mice, myocarditic lesions appeared by day 5 p.i., (Fig. 1 a) , at which time there were few per heart. Thereafter, virtually all mice developed myocarditic lesions. At 1 to 2 weeks the number of lesions peaked (Table 2) , occasionally becoming confluent. The lesions became less frequent until day 92 p.i., when few lesions were present. The cellular composition of the lesions varied with time p.i. During the first 2 weeks, the predominant cells present were lymphocytes and macrophages, with scattered neutrophils. Myocyte necrosis was present in most lesions at day 5 p.i. but was not seen after 14 days. After 2 weeks, fibroblast ingrowth occurred with collagen deposition. Between 2 and 6 weeks there was a mixture of scars and inflammatory cells, scars predominating in the latter time frame. By 92 days there were only scattered scars present with sparse inflammation ( fig. 1 b,f) ; one heart was histologically normal.
In nu/nu mice, the histological appearance of the acute myocarditic lesion was similar to that ofnu/+ mice ( Fig.   1 c) . However, there were fewer lesions on average (Table  2 ) and fibroblasts and collagen were prevalent later during the course of infection (Fig. 1 d, g ) compared with those in nu/+ hearts. Unlike hearts from nu/+ mice, lesions with active inflammation were present up to 92 days (Fig. 1 e) .
Quantification of myocarditic lesions
As shown in Fig. 2 , during the first 2 weeks, the mean percentage of lesions in both strains of mice increased in a similar manner. However, after reaching the plateau at days 9 to 14 p.i., the lesions in nu/+ mice decreased to 0.6 % at day 92. In contrast, in nu/nu mice the lesion expanded to 23.2 % (P < 0'0001) by day 92.
Titration of C VB3
The time courses of viraemia were quite similar in both nu/+ and nu/nu mice, as shown in Fig. 3 (a) . Infectious virus particles appeared in the bloodstream 1 day after inoculation and peaked at days 2 and 3 (nu/+, particles abruptly disappeared from the blood between days 4 and 5 in both nu/+ and nu/nu mice. Fig. 3 (b) shows the time curves of the virus burden on the heart.
In nu/nu mice, the mean titre between days 3 and 7 pi. was 4.2_+2.3 x 10 ~ p.f.u./mg (calculated from nine out of 12 points). Considering the mg/gl ratio, the mean titres of acute phase in the myocardium were about 10 times higher than those of whole blood. At day 9 p.i., in nu/+ mice, infectious particles started to be eradicated from the heart. At days 14 and 21, three out of four and seven out of nine nu/+ mice were virus-negative respectively.
Finally, at day 42, no virus was recovered from any of the nu/+ mice inoculated. The time span of virus recovery from nu/+ mice (up to day 21 p.i.) was slightly longer than that previously reported (Schnurr et al., 1984; Woodruff, 1980) . In contrast, in nu/nu mice infectious particles persisted in myocardial tissue with relatively constant titres (between 2"7_ 1.9 x 104 p.f.u./mg at day 3 and 7"6_+ 5.2 x 104 p.f.u./mg at day 92, four points were out of this range), which were comparable to those of nu/+ mice in the acute phase. 
Neutralization test
All the sacrificed mice at day 21 (nu/+, nine; nu/nu, 10) and 42 p.i. (nu/+, nine; nu/nu, nine) had detectable neutralizing antibody. Higher titres of over 1:64, were seen in nu/+ mice at day 21 to a greater extent than nu/nu mice (Fig. 4a) . At day 42p.i. however, the distribution of neutralization titres in both strains was similar (Fig. 4b) . relatively low copy numbers of both plus-and minusstrand RNA were synthesized (Fig. 5 i, j) in comparison with those of acute infection (Fig. 5 g, h) . Table 3 shows the duration and rates of detectable strand-specific RNA on sections from each myocardium. In euthymic mice, plus-strand RNA was detectable up to day 14 p.i. with a ratio of 100% (eight out of eight) from days 2 to 7. However, the duration of detectable minus-strand RNA was shorter (day 3 to day 7 p.i.) and the rate was also lower (four out of seven; 57 %). In athymic mice, plusstrand RNA was detected throughout the experimental period (days 3 to 42 p.i.) at a ratio of 29 out of 33 (88 %). The duration of detectable minus-strand RNA was shorter (day 7 to day 42 p.i.) and the rate was also lower (10 out of 33; 30%). Fig. 6 and 7 show the specificity and sensitivity of liquid hybridization respectively. Plus-strand RNA was detected in purified CVB3 and CVB3-infected HeLa cells. Minus-strand RNA was detected only in the infected HeLa cells. Neither plus-nor minus-strand RNA were detected in uninfected HeLa cells. Up to 2 p.f.u, of CVB3 was detectable with this technique. Fig. 8 shows the duration of detectable strand-specific RNA in the myocardium, visualized either using ethidium bromide (plus-strand) or autoradiography with a 3~p_ labelled probe (minus-strand). In nu/+ mice, both plusand minus-strand RNA was detected up to day 14 p.i., at the same ratio (day 11, four out of four; day 14, one out of four). In nu/nu mice, however both types of RNA were detected in all mice examined from days 14 to 92 p.i. These results indicated that the persistent infection in nu/nu mice was due to virus replication and not to persistence of virus particles in the myocardium.
RT-PCR
In situ hybridization
In an in vitro study, the number of in situ-positive cells with plus-strand RNA was about 10 times that of minusstrand RNA, 16 h p.i. with an m.o.i, of 0"1 (Fig. 5a, b) . The density of grains per single cell was also higher with plus-strand than with minus-strand RNA. In an in vivo study, the typical appearance of in situ-positive cells occurred as follows. At day 2 or 3 p.i. a few detectable infected myocytes with or without cellular infiltration appeared (Fig. 5 c, d ). Clusters of infected myocytes with cellular infiltration followed (Fig. 5 e) . Lines of infected myocytes and larger, more clearly demarcated lesions were seen at day 7 p.i. (Fig. 5f ). This observation was basically the same in both strains of mice. During persistent infection in nu/nu mice, it appeared that TNFo~ m RNA Prolonged TNFc~ mRNA synthesis was observed in nu/nu mice during the course of infection up to day 92 p.i. (Fig. 9) . However, the mRNA was synthesized temporarily during the acute phase of infection in nu/+ mice.
Perforin
Typical perforin-producing cells in the myocarditic lesion are shown in Fig. 10 . In nu/nu mice, these cells were 
Discussion
Persistent group B coxsackievirus infections can be established readily in vitro and in vivo, although these viruses are generally considered to be highly lytic (Schnurr & Schmidt, 1988) . The cultivated cells from hearts persistently infected with CVB3 continuously produced a low level of infectious virus particles without replenishment of susceptible cells (Schnurr & Schmidt, 1988) . This observation implied that coxsackievirus group B persistence in the heart is an important factor in chronic myocarditis. CVB3 persistent infection in the heart has been observed in several strains of athymic mice such as NFR nu/nu (Schnurr et al., 1984) , N:NIH(S)-II nu/nu (Schnurr et al., 1984) and NMRI nu/nu (Kandolf et al., 1987) . Klingel et al. (1992) reported CVB3 persistent infection in two strains of euthymic mice, A. CA/SnJ (H-2 f) and A. BY/SnJ (H-2b). The genetic backgrounds of these mice strains are different and the characteristics of CVB3 persistent infection seem to differ between them. CVB3 infection in N:NIH(S)-II nu/nu mice is characterized by a very low or undetectable serum antibody level to the virus (Schnurr et at., 1984) . In that model, CVB3 could be isolated from the heart up to 92 days p.i., which correlated with a high rate of mortality and pronounced myocarditis. Similarities in viral replication in the heart were seen between N:NIH(S)-II and C3H/HeN mice. Yet the host immune response differed, in that persistent infection was established in C3H/HeN nu/nu mice with a detectable neutralizing antibody level. In the C3H/ HeN model, we confirmed that the mode of viraemia was synchronized between nu/nu and nu/+ mice; it peaked at days 2 and 3 p.i., then declined rapidly between days 4 and 5 p.i., and ceased within a week or so. The chances of the heart cells becoming infected were therefore equal in nu/nu and nu/+ mice. During the acute phase from days 3 to 7 p.i., the yield of the virus from the hearts of nu/nu and nu/+ mice was very similar. Following the acute phase, CVB3 persistence was established in nu/nu mice, and the virus titres in the heart tissue were similar to those of the acute phase throughout the observation period, up to day 92 p.i. In contrast, the virus could not be recovered from most of the nu/+ mice after day 14p.i., as generally seen in immunocompetent mice (Chow et al., 1991) . CVB3 persistence in nu/nu or CVB3 termination in nu/+ mice obviously correlated with their myocardial histopathology. Continuing aggravation of the lesion was seen in infected nu/nu mice. However, eventual healing of the lesion occurred in nu/+ mice, which was comparable to previous reports (Okada et al., 1990; Chow et al., 1991) . The detectable level of the neutralizing antibody in C3H/HeN nu/nu mice may explain why no deaths were recorded during the observation period. It has been postulated that viruses can evoke an antibody response in athymic mice in a relatively T cell-independent fashion (Hillman et al., 1991) . A normal level of neutralizing antibody, presumably IgM, was exhibited in mice depleted of T Schmidt, 1984) . H o w e v e r , it is n o t e w o r t h y that the n e u t r a l i z i n g a n t i b o d y could neither interfere with CVB3 persistent infection in the heart, n o r p r e v e n t a g g r a v a t further spread. We made similar observations in our previous study of in situ hybridization using outbred CD-1 and Swiss nude mice (Sato et al., 1993) . However, in persistent infection with no detectable viraemia, the mode of virus transmission is not necessarily clear. Infection in a cell-to-cell manner through cellular adhesion sites may have continued in the persistent state, because in situ-positive cells also lined the myocarditic lesion of nu/nu mice, as seen in n u / + mice. The cell-tocell spread of CVB3 has also been indicated in N M R I nu/nu mice, in which the progression of infection was observed from an area with myocardial fibrosis to as yet uninfected myocytes (Kandolf et al., 1987) . However, in some athymic mice, a few infectious particles have been isolated from whole blood beyond day 14 p.i. Therefore, the possibility of infection either by cell-free virus or infected lymphoid cells (Klingel et al., 1992; Henke et al., 1992 ) cannot be excluded. The characteristics of CVB3 replication in the persistent state is not clear. R T -P C R as well as in situ hybridization have revealed the presence of minus-strand RNA intermediates in the heart of persistently infected C 3 H / H e N nu/nu mice, suggesting that replication of the virus is responsible for persistence of myocarditic lesions. However, in persistent infection, the number of in situpositive cells were fewer than in acute infection, although the yield of infectious virus was similar to that of acute infection. Klingel et al. (1992) reported that the amount of viral plus-strand RNA in myocardial cells of persistently infected mice appears to be similar to the amount of minus-strand RNA, although a great excess of the plus-strand RNA was synthesized during acute infection. These observations suggest that in persistent infection the infected heart cells contain fewer infectious particles than during acute infection, presumably due to hindrance of viral RNA replication by infiltrating cells.
The host immune response, especially that of cellmediated immunity, appears to be a critical factor in determining whether or not persistence can occur. Termination of the virus infection and healing of myocarditic lesions were generally seen in different strains of immunocompetent mice by day 21 p.i. (Chow et al., 1991) . Extensive myocarditis and high mortality, apparently due to the direct cytocidal effect of CVB3, were seen in mice with genetically determined severe combined immunodeficiency (SCID), which lack mature T and B lymphocyte functions (Chow et al., 1992) . Myocarditic lesions in SCID mice with the C3H/HeSnJ background consisted of clusters of macrophages (Mac-1 +) with a relative absence of natural killer (NK) cells. Phagocytic reactions by macrophages towards virusinfected myocytes appear to be instrumental in the final development of myocarditic lesions. However, dissemination of the virus could not be sufficiently curtailed (Chow et al., 1992) . N K cells (asialo GM1 +, CD3 , L3T4 , Lyt 2 and a macrophage marker F4/80-) are dominant ( > 70 %) in acute myocarditic lesions (day 5 to 7 p.i.) of euthymic C 3 H / H e N mice (Seko et al., 1991) . By releasing perforin (pore-forming protein), they appear to play an important role in the development of myocardial cell damage (Seko et al., 1991) . In the later stage of infection (day 9 to 11 p.i.), L3T4 (CD4)-positive cells and Lyt 2 (CD8)-positive cells had increased and represented 10 to 20 % of the infiltrating cells (Seko et al., 1991) . During persistent infection in C 3 H / H e N nu/nu mice, as many perforinproducing NK-like cells as seen in acute infection were detected in the lesions, which consisted of more than 50% asialo GMl-positive cells (data not shown). However, it is unlikely that the cell-damaging capability of NK-like cells plays an important role in eliminating the virus. Recently, Henke et al. (1992) reported that CVB3 can induce the potent release of TNF~, interleukin-1 and interleukin-6 from human monocytes without affecting their viability. They suggested that persistent CVB3 infection activates macrophages to cause tissue injury that could lead to chronic cardiomyopathy. We found prolonged synthesis of TNF~ mRNA in nu/nu mice in comparison with the short-lived synthesis of TNFe mRNA seen during acute infection of nu/+ mice. This observation might be explained by continued presence of macrophages in nu/nu mice. Although activated macrophages are considered to be primarily involved in eliminating virus and virusdamaged tissue, it can be assumed that TNFe and other cytokines released from macrophages cause myocardial cell damage individually or synergistically in nu/nu mice.
This study suggests that neither NK-like cells nor macrophages are sufficient to terminate virus dissemination in the heart of nu/nu mice in the absence of CVB3-specific, T lymphocyte-mediated immunity. It is controversial whether autoimmunity is a major cause of group B coxsackievirus-induced myocarditis. We consider that T cell-mediated immunity, including target cell killing, generally proceeds as a process for healing, rather than for aggravating the lesion. Recently Sherry et al. (1993) reported in their adoptive transfer experiment with SCID mice that both CD4-and CD8-positive T cells can act independently to protect myocardial damage from reovirus infection, and that the potential to induce cardiac damage is a property of the virus and independent of lymphocyte-based immunity. Tishon et al. (1993) also reported that cytotoxic T cells clear infectious virus and viral nucleic acid sequences from lymphocytes and monocytes/macrophages of mice persistently infected with lymphocytic choriomeningitis virus.
